Dr. Butuk is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1525 E Leigh Field Dr
Ste 150
Meridian, ID 83646Phone+1 208-888-1199Fax+1 208-888-0807
Education & Training
University of Toronto Faculty of MedicineClass of 1991
Certifications & Licensure
ID State Medical License 2003 - 2026
CA State Medical License 1994 - 2025- American Board of Family Medicine Family Medicine
Clinical Trials
- A Study of Evacetrapib (LY2484595) in Participants With High Cholesterol Start of enrollment: 2014 Oct 01
- A Study of Investigational Dulaglutide Doses in Participants With Type 2 Diabetes on Metformin Monotherapy Start of enrollment: 2016 Dec 01
- A Study of Tirzepatide (LY3298176) in Participants With Type 2 Diabetes Mellitus Start of enrollment: 2017 May 24
Publications & Presentations
PubMed
- 21 citationsThe Impact of Reactogenicity After the First Dose of Recombinant Zoster Vaccine on the Physical Functioning and Quality of Life of Older Adults: An Open-Label, Phase I...Kenneth E. Schmader, Myron J. Levin, Katrijn Grupping, Sean Matthews, David Butuk
The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences. 2019-07-12
Journal Articles
- The Impact of Reactogenicity After the First Dose of Recombinant Zoster Vaccine Upon the Physical Functioning and Quality of Life of Older Adults: An Open Phase III TrialMyron J Levin, David Butuk, Kenneth E Schmader, Charles Fogarty, Paul Hartley, Max Nevarez, Nicola P Klein, Kari Uusinarkaus, The Journals of Gerontology
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
